secwatch.observer — SEC 8-K summary
======================================

Issuer:     APTARGROUP, INC. (ATR)
CIK:        0000896622
Form:       8-K
Filed at:   2022-04-28T23:59:59+00:00
Accession:  0000896622-22-000011
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AptarGroup Q1 revenue up 9% to $845M; adjusted EPS down to $0.96 from $1.05
---------------------------------------------------------------------------

- Reported sales $845M (+9% YoY); core sales +13% with double-digit growth in all segments.
- Adjusted EPS $0.96 vs $1.05 prior year; reported EPS $0.93 included $0.19 unrealized gain in prior year.
- Pharma core sales +13%; demand for allergic rhinitis and asthma devices recovering.
- Q2 2022 adjusted EPS guidance $0.92-$1.02; midpoint +14% on constant-currency basis.
- Dividend maintained at $0.38/share; $16M share repurchases in Q1, $184M remaining authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896622/000089662222000011/0000896622-22-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896622/000089662222000011/atr-20220428.htm
  HTML page:      https://secwatch.observer/filing/0000896622-22-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer